In a recent interview, Cipla's MD and Global CEO, Umang Vohra, declared that India was in the throes of "incredible amounts of deepening of the healthcare market into tier two and six towns." ...
Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment. ...
On World COPD Day, India's first pneumotach-based portable wireless spirometer to diagnose Chronic Obstructive Pulmonary Disorder (COPD) and asthma was launched by pharmaceutical major Cipla. ...